Liraglutide: preparation and storage

Why a manufacturer lists different pH conditions

MCE lists separate liraglutide conditions: at least 12.5 mg/mL in 0.1 M NaOH and 9.52 mg/mL in water adjusted to pH 3. These illustrate condition-dependent results, not universal suitability of acid or alkali. “At least” does not establish a measured saturation limit. [1]

Do not transfer those conditions to another batch without its specification. An acidic or alkaline stock protocol requires checks of the final diluted pH and the control-matrix response. Bachem explains solvent selection based on peptide composition but provides no single recipe for all molecules. [2]

A trial before preparing the entire stock

Trial the specified vehicle and concentration on a small quantity. Allow a cold dry vial to equilibrate while sealed before opening to limit condensation. Record dissolution time, mixing, vehicle and final volume. Clear appearance does not replace a recovery assessment. [2]

Then prepare the working dilution in the actual medium and observe it over the assay period. Precipitation appearing only at this stage may reflect incompatibility during the matrix change. Adding more liraglutide does not solve the cause and makes the resulting concentration uncertain.

Calculating mass, molarity and vehicle

At 3751.20 g/mol, an educational concentration of 1 mg/mL is approximately 0.267 mM, or 267 µM. This applies only to the confirmed form with peptide content accounted for. It is not a recommended assay concentration. Another molecular weight gives another molarity at the same mg/mL. [1]

Apply c₁V₁ = c₂V₂ with matching units. Separately calculate the final fraction of acid, alkali or another stock component and include it in the control. An effect cannot be attributed only to GLP-1R when vehicle or pH differs.

Separate chemical quality from GLP-1R response

For batch comparisons, define one functional endpoint and fixed cells, timing, protein composition, vehicle and reference. A chromatographic profile answers a different question from a receptor response. A weaker signal may call for checking cells and matrix, not only reanalysing the peptide.

To investigate storage, compare fresh and stored solutions within one run. For multiple transfers, measure recovery after the entire sequence. Do not invent an acceptable-loss percentage; acceptance criteria should come from the laboratory validated method.

Storage without borrowing another product shelf life

A sealed dry vial intended for long storage generally belongs in a specification-approved freezer; a short working period may use a refrigerator. Bachem gives general conditions below −15 °C and near +4 °C respectively. A refrigerated week or month requires established stability over that interval. [2]

Solutions have separate requirements. If freezing is permitted, divide the stock into working aliquots and record dates and thaws. Lyophilizate shelf life does not become solution shelf life, and a preservative does not establish chemical stability. Assess unknown temperature excursions against documentation, not appearance.

Frequently asked questions

Can another GLP-1 peptide recipe be reused?

Only after checking the specification and compatibility. A shared target does not establish identical structure or solubility.

What does a clear stock establish?

Only that no particles were visible on inspection. Check final matrix, material recovery and the relevant analytical endpoint separately.

Can the prepared solution be frozen?

The specification for its vehicle and concentration determines this; when permitted, use aliquots and maintain a thaw record.

Sources

1. MedChemExpress: Liraglutide, HY-P0014. Manufacturer reagent record and conditions checked 26 October 2026; not a Longeva batch certificate.
2. Bachem: Handling and Storage Guidelines for Peptides. General peptide principles; checked 26 October 2026.

Product and current sizes · Monograph and research · COA

A laboratory guide for research material; no human-use regimen is provided.